Navigation Links
FRT flanked Ampicillin Selection Cassette (FRT-amp-FRT) from Gene Bridges GmbH

ProductsFRT flanked Ampicillin Selection Cassette (FRT-amp-FRT) from Gene Bridges GmbH
Company Gene Bridges GmbH
Item FRT flanked Ampicillin Selection Cassette (FRT-amp-FRT)
Price 
Description The FRT-amp-FRT cassette is designed to allow ampicillin selection in prokaryotic cells.
The prokaryotic promoter gb2 driving the gene for ampicillin resistance is a slightly modified version of the Em7 promoter. It mediates higher transcription efficiency than the generally used Tn5 promoter. A synthetic polyadenylation signal terminates the ampicillin expression. The cassette is flanked by FRT sites for later excision by Flp recombinase. Unique NotI and XhoI sites flank the cassette for convenient cloning with restriction sites.
Using the provided PCR template one can easily create a FRT-amp-FRT cassette flanked by any other restriction sites to clone the cassette into the vector of choice. The restriction sites can be introduced by adding the corresponding sequence in the PCR primer. The template can easily be used to engineer the E.coli genome by Red/ET Recombination.
The FRT-amp-FRT cassette is not linear but plasmid based (3502 bp in size). Due to its R6K origin the plasmid cannot replicate in most E.coli strains. The PCR product can therefore be used directly for downstream applications without any further purification.
Info Gene Bridges GmbH
Commercial Centre
Im Neuenheimer Feld 584
69120 Heidekberg, Germany
Customer Service: +49 (0)6221 13708 10
Fax Number: +49 (0)6221 13708 29
Web Site: http://www.Genebridges.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. FRT flanked, Pro and Euk. Neomycin Selection Cassette (FRT-PGK-gb2-neo-FRT) from Gene Bridges GmbH
2. loxP flanked, Pro and Euk. Neomycin Selection Cassette (loxP-PGK-gb2-neo-loxP) from Gene Bridges GmbH
3. FRT flanked, Pro and Euk. Neomycin Selection Cassette plus loxP site(FRT-PGK-gb2-neo-FRT-loxP) from Gene Bridges GmbH
4. loxP flanked Chloramphenicol Selection Cassette (loxP-cm-loxP) from Gene Bridges GmbH
5. loxP flanked Ampicillin Selection Cassette (loxP-amp-loxP) from Gene Bridges GmbH
6. Mouse Anti-Ampicillin Monoclonal Antibody, Unconjugated, Clone 164-12-2 from Abcam
7. EasySep Biotin Selection Kit, Other from StemCell Technologies, Inc.
8. EasySep PE Selection Kit, Other from StemCell Technologies, Inc.
9. EasySep PE Selection Kit, Other, Starter Kit from StemCell Technologies, Inc.
10. EasySep FITC Selection Kit, Other from StemCell Technologies, Inc.
11. FailSafe PCR PreMix Selection Kit from EPICENTRE Biotechnologies
(Date:11/27/2019)... ... November 26, 2019 , ... Personalized Stem Cells, Inc (“PSC”), ... Arthritis Foundation and hosted by Dr. Steven Sampson and Dr. Danielle Aufiero of the ... October 23, 2019, highlighted the ongoing efforts to promote research, educate the public, and ...
(Date:11/19/2019)... ... November 19, 2019 , ... Project Lifeline ... Drug Stores (NACDS) Foundation to address substance use disorder (SUD) – will ... individuals who have led to the program’s effectiveness in preventing and treating opioid abuse ...
(Date:11/14/2019)... ... November 13, 2019 , ... ... Peterson, RAC , a regulatory affairs and program management executive with more than ... device industries, has joined the firm as an Expert Consultant. , Robert ...
Breaking Biology News(10 mins):
(Date:12/2/2019)... ... December 02, 2019 , ... Registration is now open for the ... held at the Hynes Convention Center May 12-15, 2020, in Boston. The meeting is ... scientists, physicians, patient advocates, and other stakeholders with the goal of advancing gene and ...
(Date:11/22/2019)... , ... November 22, 2019 ... ... engineering firm, hosted a live webinar covering a step-by-step cold chain validation ... antibody-drug conjugates, and cell therapies. Targeting complex cold chain biopharmaceutical industry leaders, ...
(Date:11/20/2019)... (PRWEB) , ... November 20, 2019 , ... ... worldwide production of about 8,500 microturbine electrical power generation units from 2019-2028. The ... significant increase over 2017's projection of 3,821 units worth $569 million. , ...
(Date:11/12/2019)... ... 12, 2019 , ... REPROCELL Inc. a stem cell and ... Pharma to provided preclinical screening and drug sensitivity for its portfolio of oncology ... of unique and genetically edited cell lines from various tumors. The data generated ...
Breaking Biology Technology: